Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 637Head & Neck 94Breast 40Genitourinary 17Gynecologic 16Tumor-Agnostic 13Thoracic 7Dermatologic 7Other solid neoplasm 5Endocrine 4Sarcoma 2Other neoplasm 1Other 1Lymphoid 1

Conditions

Lymphoma 1

Interventions

Rituximab 689Cyclophosphamide 614Vincristine 285Etoposide 272Doxorubicin 271Cytarabine 230Prednisone 228Methotrexate 221fludarabine phosphate 189Filgrastim 187Dexamethasone 180fludarabine 175Lenalidomide 165Radiotherapy 128Melphalan 127Peripheral Blood Stem Cell Transplantation 123Busulfan 118Bendamustine Hydrochloride 116Granulocyte Colony-Stimulating Factor 113Bortezomib 112ibrutinib 111Mycophenolic Acid 110venetoclax 106Whole-Body Irradiation 106Tacrolimus 105obinutuzumab 104Gemcitabine 92zanubrutinib 81Specimen Handling 80Cyclosporine 76

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fluorouracil × Lymphoid × Clear all
NCT00002524 2012-07-30

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
46 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡